Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Independent

Supplier

The Coronary Microcirculation Re-explored
Author(s): Ahmed Elamin , Mustafa Abdimalik , Mohanad Abdelrahim , et al Added: 1 week ago

Prevention & Chronic Conditions
Amir Lerman
Research Area(s) / Expertise:

Expertise

Heart Failure
The research interests of Amir Lerman, M.D., are centered on coronary physiology and the role of the endothelium in regulating coronary vascular tone. DrLerman and colleagues use state-of-the-art technology, including intracoronary Doppler, intracoronary pressure assessment and intravascular ultrasound. Research is carried out in the Center for Coronary Physiology and Imaging, part of Mayo Clinic… View more
Research Area(s) / Expertise:

Expertise

Heart Failure
Job title: Professor of Clinical Cardiology
Dr Peter Collins is Professor of Clinical Cardiology, National Heart and Lung Institute, Imperial College London, and Honorary Consultant Cardiologist at the Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust. Dr Collins’ research interests include coronary flow control mechanisms, both in normal and disease states including ischemic heart disease, hypertension and… View more
AHA 25: The AI-SCREEN-CA Study
Author(s): Nobuyuki Kagiyama Added: 2 days ago
AHA 2025 - Prof Nobuyuki Kagiyama (Juntendo University School of Medicine, Tokyo, JP) joins us to share findings from the AI-SCREEN-CA study investigating whether an artificial intelligence-based software for checking real-world echocardiography can improve the early and accurate detection of hidden cardiac amyloidosis.Findings showed that this AI software identified around 5% of the entire… View more

Heart Failure

Imaging & Diagnostics
AHA 25 Late-breaking Discussion: The VESALIUS-CV Trial
Author(s): Erin A Bohula , Harriette Van Spall Added: 1 day ago
AHA Scientific Sessions 2025 – Late-breaker host Dr Harriette Van Spall (McMaster University, CA) is joined by Dr Erin A Bohula (Brigham & Women's Hospital, US) to discuss the primary results of the VESALIUS-CV trial, a large-scale, phase 3, double-blind, randomised, placebo-controlled study sponsored by Amgen.The VESALIUS-CV trial (NCT03872401) evaluated the impact of evolocumab, a PCSK9… View more

Heart Failure

Prevention & Chronic Conditions
AHA 25: HFpEF as an Adipose Tissue Disorder
Author(s): Milton Packer Added: 2 days ago
AHA Scientific Sessions 2025 - Dr Milton Packer (Baylor University Medical Center, US) joins us to discuss his novel unifying hypothesis that heart failure with preserved ejection fraction arises primarily from visceral adipose tissue dysfunction and altered adipokine signaling, rather than as a heterogeneous disorder driven by multiple comorbidities.Interview Questions:Can you explain the core… View more

Cardiovascular Renal Metabolic

Heart Failure
AHA 25: Pregnancy and CKM Health: Essential Knowledge for Cardiologists
Author(s): Emily Lau Added: 3 days ago
AHA Scientific Sessions 2025 - Dr Emily Lau (Brigham and Women's Hospital, US) joins us to discuss what cardiologists need to know about the intersection of pregnancy and cardiovascular-kidney-metabolic health, from pre-conception counseling through long-term postpartum care.Interview Questions:Why is it important for cardiologists to understand the relationship between pregnancy and… View more

Cardiovascular Renal Metabolic

CV Disease in Special Populations
AHA 25: Beta-Blocker Therapy Post MI in Patients with Preserved LVEF
Author(s): Anna Meta Dyrvig Kristensen Added: 2 days ago
AHA Scientific Sessions 2025 – Dr Anna Meta Dyrvig Kristensen (Copenhagen University Hospital, Bispebjerg and Frederiksberg, DK) presents an individual patient data meta-analysis examining beta-blocker therapy after myocardial infarction in patients with preserved left ventricular ejection fraction.This comprehensive meta-analysis pooled individual patient data from five randomized controlled… View more

Heart Failure
AHA 25: TUXEDO-2: Ticagrelor vs Prasugrel in Diabetic PCI
Author(s): Sripal Bangalore , Harriette Van Spall Added: 5 days ago
AHA Scientific Sessions 2025 — Late-breaker host Dr Harriette Van Spall (McMaster University, CA) was joined by the TUXEDO-2 Principal Investigator, Dr Sripal Bangalore to present the findings of this late-breaking randomized trial comparing ticagrelor versus prasugrel in patients with diabetes mellitus and multivessel coronary artery disease undergoing percutaneous coronary intervention (PCI)… View more

Anticoagulation

Intervention